Interleukin-4 is a potent mitogen for capillary endothelium

Area of Science:

• Endocrinology
• Cell Biology
• Vascular Biology

Background:

• Interleukin-4 (IL-4) is recognized as a mitogen for endothelial cells.
• Endothelial cells form blood vessels and play critical roles in vascular health and disease.

Purpose of the Study:

• To investigate and compare the mitogenic effects of IL-4 on microvascular (HACE) and large vessel (HUVEC) endothelial cells.
• To characterize the binding of IL-4 to endothelial cells and determine receptor affinity.

Main Methods:

• Assessing endothelial cell proliferation using 3H-thymidine incorporation and cell counting.
• Measuring specific binding of radioiodinated IL-4 to HACE and HUVEC cells.
• Performing Scatchard analysis to determine IL-4 receptor binding kinetics.

Main Results:

• IL-4 demonstrated significant growth promotion in HACE cells (50% of FGF activity) but weaker activity in HUVEC cells (12% of FGF activity).
• Optimal IL-4 stimulation occurred at 1 nM, confirmed by both proliferation assays.
• High-affinity IL-4 receptors were identified on both HACE (Kd = 80 pM, 358 receptors/cell) and HUVEC (Kd = 88 pM, 2,580 receptors/cell) cells.

Conclusions:

• Interleukin-4 exhibits potent mitogenic activity on capillary endothelium (HACE) compared to large vessel endothelium (HUVEC).
• This differential activity positions IL-4 uniquely among known endothelial cell growth factors.
• The presence of high-affinity IL-4 receptors underlies its specific effects on different endothelial cell types.